Tim Greaney

Thomas (Tim) Greaney, JD, is a Visiting Professor of Law at UC Hastings College of Law in San Francisco and Distinguished Senior Fellow with the UC Hastings/UCSF Consortium on Law, Science & Health Policy. He is also Chester A. Myers Emeritus Professor of Law at Saint Louis University School of Law where he served as Director of the Center for Health Law Studies. His research focuses on the application of antitrust law to the health care sector, health care financing, and health care law and policy. He has written over 60 scholarly articles and chapters and is co-author of the nation’s leading health law casebook, HEALTH LAW: CASES, MATERIALS AND PROBLEMS (West, 8th edition 2018) and a treatise on health law, HEALTH LAW (WEST 3RD ED. 2014). He has testified on health care competition issues before the Judiciary Committees of the United States Senate and House of Representatives, the California Department of Insurance, and has spoken at workshops of the Federal Trade Commission. He has commented on health policy and law issues in the New York Times, Wall Street Journal and many other publications. Before entering academia, he served as an Assistant Chief in the U.S. Department of Justice Antitrust Division, supervising health care antitrust litigation. Professor Greaney has been named Health Law Professor of the Year by the American Society of Law and Medicine and has been a Fulbright Fellow studying European Community competition law in Brussels, Belgium. He received his B.A. from Wesleyan University and his J.D. from Harvard Law School.

Invigorating Competition in Health Care Markets: Is Rate Regulation Needed?

It now appears that market concentration may be the leading cause of America’s health care cost crisis. If the United States is...

Latest news

Should the European Union Require Tech Firms to Adopt a Common Charger?

According to a new European Commission directive expected to be approved in the next few months, tech firms will have to use...

Chart of the Week: Economists Don’t Think Congress Should Make Price Gouging Illegal

Most economists disagree with a new bill in the US that would set limits on "unconscionably excessive prices," according to a recent...

Neoliberal Economists Are Giving Biden Bad Advice on Inflation

To spare the economy from the pain of further interest rate hikes, the President should aggressively pursue anticompetitive conduct by companies in...

How Would the Big Tech Self-Preferencing Bill Affect Users? 

The Senate looks to be nearing a vote on the American Innovation and Choice Online Act, which would prohibit gatekeeping digital platforms...

New eBook Revisits George Stigler’s Theory of Regulatory Capture 50 Years Later

To mark the 50-year anniversary of George Stigler’s seminal piece, “The Theory of Economic Regulation” we are publishing a new eBook examining...

Firms Gerrymander Ownership of Polluting Plants to Reap Public and Regulatory Benefits

New research has discovered that many companies who appear to sell, or ‘divest,’ their toxic plants, actually retain relationships with their buyers....

How Should Antitrust Deal With Facebook? A Stigler Center Panel Investigates

Panelists at the Stigler Center’s recent antitrust conference look at the antitrust case against Facebook and discuss potential theories of harm, as...